- Home
- / Sanofi Pasteur
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sanofi Pasteur financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
€2.8 B
FY, 2021
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 2.4B | 2.5B | 2.8B |
| Cost of goods sold | 370.0M | 398.0M | 505.0M |
| Gross profit | 2.0B | 2.1B | 2.3B |
| Gross profit margin, % | 84.4% | 84.1% | 82.2% |
| General and administrative expense | 573.0M | 601.0M | 622.0M |
| Operating expense total | 2.0B | 2.1B | 2.3B |
| Depreciation and amortization | 453.0M | 440.0M | 401.0M |
| EBIT | 734.0M | 731.0M | 714.0M |
| EBIT margin, % | 30.9% | 29.3% | 25.1% |
| Pre tax profit | 715.0M | 710.0M | 695.0M |
| Income tax expense | 227.0M | 187.0M | 162.0M |
| Net Income | 664.0M | 575.0M | 605.0M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |